Oct 11
Current report
8-K
Financial results
OFIX · Orthofix Medical Inc. · Documents
$8.92
-0.80 (-8.23%)
At close · Nov 5
Return incl. dividend (before tax)
Play latest call
Q2 2026 earnings call transcript
Market Cap
$392.26M
Shares
40.73M
Volume · Nov 5
1.36M
Avg daily vol (3M)
404.83K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
The company's filings, earnings calls and investor events, most recent first. Search and read these filings from Claude or ChatGPT with the SEC filings MCP server →
2022
Aug 5
Earnings call
Q2 2022 earnings call
Aug 5
Current report
8-K
Financial results, Regulation FD disclosure
Aug 5
Quarterly report
10-Q
FY2022 Q2, ended Jun 30
Quarterly report for FY2022 Q2
Revenue $118.07M
▼ 2.7%
Net income $2.49M
▲ 2.9%
Diluted EPS $0.12
▲ unchanged
Jun 7
Current report
8-K
Events of Jun 6
Director or officer change, or executive pay, Shareholder vote results
May 6
Earnings call
Q1 2022 earnings call
May 6
Current report
8-K
Financial results, Regulation FD disclosure
May 6
Quarterly report
10-Q
FY2022 Q1, ended Mar 31
Quarterly report for FY2022 Q1
Revenue $106.42M
▲ 0.8%
Net loss $4.46M
Diluted EPS -$0.22
Apr 27
Proxy statement
DEF 14A
Meeting Jun 6, 2022
Proxy statement
Apr 27
Proxy statement
DEFA14A
Proxy statement
Apr 8
Current report
8-K
Events of Apr 5
Director or officer change, or executive pay
Feb 25
Earnings call
Q4 2021 earnings call
Feb 25
Current report
8-K
Financial results, Regulation FD disclosure
Feb 25
Annual report
10-K
FY2021, ended Dec 31
Annual report for FY2021
Revenue $464.48M
▲ 14.2%
Net loss $38.38M
Diluted EPS -$1.95
Jan 10
Current report
8-K
Financial results, Regulation FD disclosure
2021
Dec 14
Current report
8-K
Events of Dec 13
Director or officer change, or executive pay, Regulation FD disclosure
Nov 5
Earnings call
Q3 2021 earnings call
Nov 5
Current report
8-K
Financial results, Regulation FD disclosure
Nov 5
Quarterly report
10-Q
FY2021 Q3, ended Sep 30
Quarterly report for FY2021 Q3
Revenue $112.43M
▲ 1.3%
Net loss $2.17M
Diluted EPS -$0.11
Sep 29
Current report
8-K
Regulation FD disclosure
Sep 23
Current report
8-K
Events of Sep 22
Director or officer change, or executive pay, Regulation FD disclosure
Aug 6
Earnings call
Q2 2021 earnings call
Aug 6
Current report
8-K
Financial results, Regulation FD disclosure
Aug 6
Quarterly report
10-Q
FY2021 Q2, ended Jun 30
Quarterly report for FY2021 Q2
Revenue $121.39M
▲ 66.0%
Net income $2.42M
Diluted EPS $0.12
Jul 6
Current report
8-K
Events of Jul 3
Director or officer change, or executive pay
Jun 21
Current report
8-K
Director or officer change, or executive pay, Shareholder vote results
Apr 30
Earnings call
Q1 2021 earnings call
Apr 30
Current report
8-K
Financial results, Regulation FD disclosure
Apr 30
Quarterly report
10-Q
FY2021 Q1, ended Mar 31
Quarterly report for FY2021 Q1
Revenue $105.59M
▲ 0.7%
Net loss $5.82M
Diluted EPS -$0.30
Apr 30
Proxy statement
DEFR14A
Proxy statement
Apr 29
Proxy statement
DEF 14A
Meeting Jun 21, 2021
Proxy statement
Apr 29
Proxy statement
DEFA14A
Proxy statement
Apr 7
Current report
8-K
Events of Apr 5
Director or officer change, or executive pay, Regulation FD disclosure
Feb 26
Earnings call
Q4 2020 earnings call
Feb 26
Current report
8-K
Financial results, Regulation FD disclosure
Feb 26
Annual report
10-K
FY2020, ended Dec 31
Annual report for FY2020
Revenue $406.56M
▼ 11.6%
Net income $2.52M
Diluted EPS $0.13
Jan 29
Current report
8-K
Events of Jan 28
Charter or bylaw amendment, or fiscal year change
Jan 12
Current report
8-K
Financial results, Regulation FD disclosure
2020
Nov 5
Earnings call
Q3 2020 earnings call
Nov 5
Current report
8-K
Financial results, Regulation FD disclosure
Nov 5
Quarterly report
10-Q
FY2020 Q3, ended Sep 30
Quarterly report for FY2020 Q3
Revenue $110.99M
▼ 2.2%
Net income $4.65M
Diluted EPS $0.24
Sep 22
Current report
8-K
Regulation FD disclosure, Other events
Sep 14
Current report
8-K
Regulation FD disclosure
Aug 6
Earnings call
Q2 2020 earnings call
Aug 6
Current report
8-K
Financial results, Regulation FD disclosure
Aug 6
Quarterly report
10-Q
FY2020 Q2, ended Jun 30
Quarterly report for FY2020 Q2
Revenue $73.14M
▼ 36.9%
Net loss $18.42M
Diluted EPS -$0.96
Jun 9
Current report
8-K
Events of Jun 8
Director or officer change, or executive pay, Shareholder vote results, Regulation FD disclosure
May 20
Proxy statement
DEFR14A
Proxy statement
May 8
Earnings call
Q1 2020 earnings call
May 8
Current report
8-K
Financial results, Regulation FD disclosure
Showing 101–150 of 160 documents
Key facts
CIK
884624
CUSIP
68752M108
13F (30d)
47 filings
35 filers
Visit website
Investor relations